US Cuts WHO Funding, Boosts Gavi Vaccine Alliance with $600 Million

In a significant shift in its global health funding strategy, the United States has announced a substantial allocation of $600 million to Gavi, the Vaccine Alliance, while simultaneously severing its financial ties with the World Health Organization (WHO). This decision marks a notable financial setback for the WHO, a key player in global health initiatives, particularly in the wake of the COVID-19 pandemic. The announcement was made through a joint statement issued by the US Department of State and the Department of Health and Human Services, which emphasized that the US government would not channel any funding to the WHO via Gavi. This move aligns with directives from President Donald Trump, who has instructed Health and Human Services Secretary Robert Kennedy Jr. and Secretary of State Marco Rubio to negotiate reforms with Gavi as a prerequisite for any future US support.

The decision has garnered mixed reactions, particularly from US Republican Senator Susan Collins, who has been an advocate for reinstating US funding for global vaccination efforts. Collins expressed her approval of the new funding directed towards Gavi, which plays a crucial role in enhancing access to vaccines worldwide. The State Department highlighted that Gavi has committed to transitioning away from mercury-containing vaccines in favor of safer, mercury-free alternatives, collaborating with its board and partner nations to achieve this goal. This funding decision comes against a backdrop of historical tensions between the Trump administration and the WHO, particularly following Trump's criticism of the organization's handling of the pandemic. In 2020, Trump had ordered a temporary halt to US funding to the WHO, accusing it of promoting misinformation from China regarding the virus, which he argued contributed to the pandemic's escalation.